Does RISANKIZUMAB-RZAA Cause Dyspnoea? 816 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 816 reports of Dyspnoea have been filed in association with RISANKIZUMAB-RZAA. This represents 1.3% of all adverse event reports for RISANKIZUMAB-RZAA.
816
Reports of Dyspnoea with RISANKIZUMAB-RZAA
1.3%
of all RISANKIZUMAB-RZAA reports
24
Deaths
410
Hospitalizations
How Dangerous Is Dyspnoea From RISANKIZUMAB-RZAA?
Of the 816 reports, 24 (2.9%) resulted in death, 410 (50.2%) required hospitalization, and 9 (1.1%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 816 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Dyspnoea Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA